Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandro Isidori

Showing results (51-60 of 89) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|May 31, 2021
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With NilotinibFederica Loscocco, Giuseppe Visani, Annamaria Ruzzo, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
Acta Haematologica|December 5, 2012
Complete clearance of Ph+ metaphases after 3 months is a very early indicator of good response to imatinib as front-line treatment in chronic myelogenous leukemiaRoberto Latagliata, Alessandro Isidori, Massimo Breccia, et al.
Frontiers in Oncology|September 24, 2021
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt LymphomaIrene Bagaloni, Axel Visani, Sara Biagiotti, et al.
Blood Advances|October 19, 2020
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AMLGiuseppe Visani, Federica Loscocco, Mike Dennis, et al.
British Journal of Haematology|January 20, 2007
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scansAnna Mele, Massimo Offidani, Giuseppe Visani, et al.
Blood|December 14, 2006
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cellsAntonio Curti, Simona Pandolfi, Barbara Valzasina, et al.
Cancer Research|May 25, 2017
Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal RemodelingClaudio Tripodo, Alessia Burocchi, Pier Paolo Piccaluga, et al.
Frontiers in Oncology|May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We StandAlessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Blood|July 28, 2011
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patientsAntonio Curti, Loredana Ruggeri, Alessandra D'Addio, et al.
Pageof 9

Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|May 31, 2021
Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With NilotinibFederica Loscocco, Giuseppe Visani, Annamaria Ruzzo, et al.
The Oncologist|April 26, 2012
Tailored therapy in an unselected population of 91 elderly patients with DLBCL prospectively evaluated using a simplified CGAAttilio Olivieri, Guido Gini, Caterina Bocci, et al.
Acta Haematologica|December 5, 2012
Complete clearance of Ph+ metaphases after 3 months is a very early indicator of good response to imatinib as front-line treatment in chronic myelogenous leukemiaRoberto Latagliata, Alessandro Isidori, Massimo Breccia, et al.
Frontiers in Oncology|September 24, 2021
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt LymphomaIrene Bagaloni, Axel Visani, Sara Biagiotti, et al.
Blood Advances|October 19, 2020
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AMLGiuseppe Visani, Federica Loscocco, Mike Dennis, et al.
British Journal of Haematology|January 20, 2007
Technetium-99m sestamibi scintigraphy is sensitive and specific for the staging and the follow-up of patients with multiple myeloma: a multicentre study on 397 scansAnna Mele, Massimo Offidani, Giuseppe Visani, et al.
Blood|December 14, 2006
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cellsAntonio Curti, Simona Pandolfi, Barbara Valzasina, et al.
Cancer Research|May 25, 2017
Persistent Immune Stimulation Exacerbates Genetically Driven Myeloproliferative Disorders via Stromal RemodelingClaudio Tripodo, Alessia Burocchi, Pier Paolo Piccaluga, et al.
Frontiers in Oncology|May 27, 2021
Immunotherapy in Acute Myeloid Leukemia: Where We StandAlessandro Isidori, Claudio Cerchione, Naval Daver, et al.
Blood|July 28, 2011
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patientsAntonio Curti, Loredana Ruggeri, Alessandra D'Addio, et al.
Pageof 9